MLD10 in the Prevention of Migraine in Adults

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Migraine
Interventions
DRUG

MLD10

DRUG

Placebo

Trial Locations (9)

30039

Dr. B. Abraham, P.C., Snellville

32765

Physician Associates of Florida Research Department, Oviedo

37203

Nashville Neuroscience Group, Nashville

38020

Baptist Memorial Hospital, Memphis

49009

Westside Family Medical Center, P.C., Kalamazoo

63303

StudyMetrix Research, City of Saint Peters

65807

Clinvest Research, LLC, Springfield

92011

The Research Center of Southern California, Carlsbad

94109

San Francisco Clinical Research Center, San Francisco

Sponsors
All Listed Sponsors
collaborator

Clinvest

OTHER

lead

Pharmalyte Solutions LLC

INDUSTRY